These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 10554642)
1. Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors. Pape H; Laws HJ; Burdach S; van Kaik B; Glag M; Gripp S; Wittkamp M; Jürgens H; Göbel U; Schmitt G Strahlenther Onkol; 1999 Oct; 175(10):484-7. PubMed ID: 10554642 [TBL] [Abstract][Full Text] [Related]
2. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report. Laws HJ; Burdach S; van Kaick B; Engel B; Dirksen U; Körholz D; Pape H; Kahn T; Merck H; Schmitz M; Heyll A; Dockhorn-Dworniczak B; Jürgens H; Göbel U Strahlenther Onkol; 1999 Oct; 175(10):488-94. PubMed ID: 10554643 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486 [TBL] [Abstract][Full Text] [Related]
4. Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients? Laws HJ; van Kaick B; Pape H; Paulussen M; Göbel U Onkologie; 2003 Dec; 26(6):573-7. PubMed ID: 14709933 [TBL] [Abstract][Full Text] [Related]
5. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study. Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286 [TBL] [Abstract][Full Text] [Related]
7. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966 [TBL] [Abstract][Full Text] [Related]
8. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. Burdach S; Jürgens H; Peters C; Nürnberger W; Mauz-Körholz C; Körholz D; Paulussen M; Pape H; Dilloo D; Koscielniak E J Clin Oncol; 1993 Aug; 11(8):1482-8. PubMed ID: 8101562 [TBL] [Abstract][Full Text] [Related]
9. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
10. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors. Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663 [TBL] [Abstract][Full Text] [Related]
12. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U; Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267 [TBL] [Abstract][Full Text] [Related]
13. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol. Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857 [TBL] [Abstract][Full Text] [Related]
14. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881 [TBL] [Abstract][Full Text] [Related]
15. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284 [TBL] [Abstract][Full Text] [Related]
16. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
18. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741 [TBL] [Abstract][Full Text] [Related]
19. Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue. Burdach S; Peters C; Paulussen M; Nürnberger W; Wurm R; Wernet P; Dilloo D; Voehringer R; Gadner H; Göbel U Bone Marrow Transplant; 1991; 7 Suppl 2():95. PubMed ID: 1678978 [No Abstract] [Full Text] [Related]
20. [Ewing's sarcoma--report of 18 cases]. Gu BH Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):452-4. PubMed ID: 2634546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]